Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

Early diagnosis and new treatments are crucial to prevent permanent hair loss in scarring alopecia.

Sparse hairs below frontal hairline can indicate early male balding.

More research is needed to better understand and treat Fibrosing Frontal Alopecia.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

A new treatment using AGED to modulate PPAR-γ shows promise for treating scarring hair loss by protecting and repairing hair follicle cells.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Hair loss in male frontal fibrosing alopecia may spare areas covered by a wristwatch.

Alopecia frontal fibrosante affects facial vellus hair and can be diagnosed with dermatoscopy.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Postmenopausal frontal fibrosing alopecia may be a unique condition linked to postmenopausal changes.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Daughters with affected mothers may develop frontal fibrosing alopecia early.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

The study found that Frontal Fibrosing Alopecia in North-East India mainly affects middle-aged women and is often associated with lichen planus pigmentosus.

Increased sunscreen use may be linked to frontal fibrosing alopecia in Hispanic females.